Abivax SA expected to post a loss of 73 cents a share - Earnings Preview

Abivax SA

30/05/2025 15:02

Abivax SA ABVX.OQ, ABVX.O is expected to report resultson June 2 for the period ending March 31 2025

The Paris Ile-de-france-based  company is expected to report revenue of €3.112 million, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Abivax SA is for a loss of 73 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Abivax SA is $33.00​, above​ its last closing price of $6.02. ​​​

This summary was machine generated May 30 at 14:02 GMT.  All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)